World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
65
Citations
16248
World Ranking
2496
National Ranking
48

Sven Hoffner publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Sven Hoffner sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 215 publications — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Sven Hoffner D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Sven Hoffner sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 65 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Sven Hoffner is affiliated with the Karolinska Institute in Sweden and has a research focus primarily in the field of Medicine, with substantial work in Infectious Diseases, Epidemiology, Surgery, Molecular Biology, and Immunology. Their research extensively covers topics related to tuberculosis and infectious diseases, with a particular emphasis on Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis, and Antibiotic Resistance in Bacteria.

The scientist's recent publications include several studies on tuberculosis and related infections. Notable papers include:

  • "Pyrazinamide Susceptibility Is Driven by Activation of the SigE-Dependent Cell Envelope Stress Response in Mycobacterium tuberculosis" (2022, mBio)
  • "Rising challenge of multidrug-resistant tuberculosis in China: a predictive study using Markov modeling" (2020, Infectious Diseases of Poverty)
  • "Atypical Genetic Basis of Pyrazinamide Resistance in Monoresistant Mycobacterium tuberculosis" (2021, Antimicrobial Agents and Chemotherapy)
  • "Dynamics of Extensive Drug Resistance Evolution of Mycobacterium tuberculosis in a Single Patient During 9 Years of Disease and Treatment" (2020, The Journal of Infectious Diseases)
  • "Treatment quality and outcome for multidrug-resistant tuberculosis patients in four regions of China: a cohort study" (2020, Infectious Diseases of Poverty)

The venues where Sven Hoffner frequently publishes include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Infectious Diseases of Poverty
  • Antimicrobial Agents and Chemotherapy
  • International Journal of Mycobacteriology
  • Zenodo (CERN European Organization for Nuclear Research)

Among frequent co-authors working with Sven Hoffner are:

  • Faramarz Valafar
  • Samuel J. Modlin
  • Jim Werngren
  • Mikael Mansjö
  • Derek Conkle-Gutierrez

The main fields of study and subfields related to Hoffner's work are characterized by a strong focus on medical research concerning infectious diseases, particularly tuberculosis. The main topics of work cover:

  • Tuberculosis Research and Epidemiology
  • Mycobacterium research and diagnosis
  • Pneumonia and Respiratory Infections
  • Cancer therapeutics and mechanisms
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Antibiotic Resistance in Bacteria
  • Infectious Diseases and Tuberculosis

Best Publications

  • A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis.

    Koen Andries;Peter Verhasselt;Jerome Guillemont;Hinrich W. H. Göhlmann

  • Global trends in resistance to antituberculosis drugs. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.

    Marcos A. Espinal;Adalbert Laszlo;Lone Simonsen;Fadila Boulahbal

  • Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage

    Matthias Merker;Camille Blin;Stefano Mona;Nicolas Duforet-Frebourg

  • Mycobacterium tuberculosis lineage 4 comprises globally distributed and geographically restricted sublineages.

    David Stucki;David Stucki;Daniela Brites;Daniela Brites;Leïla Jeljeli;Mireia Coscolla;Mireia Coscolla

  • A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis

    Paolo Miotto;Belay Tessema;Elisa Tagliani;Leonid Chindelevitch

  • Effect of rpoB Mutations Conferring Rifampin Resistance on Fitness of Mycobacterium tuberculosis

    Deneke H. Mariam;Yohannes Mengistu;Sven E. Hoffner;Dan I. Andersson

  • Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance

    Abigail L. Manson;Keira A. Cohen;Keira A. Cohen;Thomas Abeel;Thomas Abeel;Christopher A. Desjardins

  • Rates and Mechanisms of Resistance Development in Mycobacterium tuberculosis to a Novel Diarylquinoline ATP Synthase Inhibitor

    E Huitric;E Huitric;P Verhasselt;Anil Koul;K Andries

  • Spread of Drug-Resistant Pulmonary Tuberculosis in Estonia

    Annika Krüüner;Annika Krüüner;Sven E. Hoffner;Heinart Sillastu;Manfred Danilovits

  • Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis.

    Freddie Bwanga;Freddie Bwanga;Sven Hoffner;Melles Haile;Moses L Joloba

  • Fluoroquinolone Resistance in Mycobacterium tuberculosis and Mutations in gyrA and gyrB

    Andrea Von Groll;Anandi Martin;Pontus Jureen;Sven Hoffner

  • Origin and primary dispersal of the Mycobacterium tuberculosis Beijing genotype: Clues from human phylogeography

    Igor Mokrousov;Ho Minh Ly;Tatiana Otten;Nguyen Ngoc Lan

  • Extensively Drug-Resistant Tuberculosis: 2 Years of Surveillance in Iran

    Mohamad Reza Masjedi;Parissa Farnia;Setara Sorooch;Majid Valiollah Pooramiri

  • Microevolution of extensively drug-resistant tuberculosis in Russia

    Nicola Casali;Vladyslav Nikolayevskyy;Yanina Balabanova;Olga Ignatyeva

  • Rapid and Inexpensive Drug Susceptibility Testing of Mycobacterium tuberculosis with a Nitrate Reductase Assay

    K. A. Kristian Ängeby;Lisbeth Klintz;Sven E. Hoffner

  • Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk.

    Alena Skrahina;Henadz Hurevich;Aksana Zalutskaya;Evgeni Sahalchyk

  • In Vitro Antimycobacterial Spectrum of a Diarylquinoline ATP Synthase Inhibitor

    Emma Huitric;Peter Verhasselt;Koen Andries;Sven E. Hoffner;Sven E. Hoffner

  • Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project

    Matteo Zignol;Anna S. Dean;Natavan Alikhanova;Sönke Andres

  • Pyrazinamide Resistance and pncA Gene Mutations in Mycobacterium tuberculosis

    Pontus Juréen;Jim Werngren;Juan-Carlos Toro;Sven Hoffner

  • Inhibition of bacterial thioredoxin reductase: an antibiotic mechanism targeting bacteria lacking glutathione.

    Jun Lu;Alexios Vlamis-Gardikas;Karuppasamy Kandasamy;Rong Zhao

Frequent Co-Authors

Gunilla Källenius
Gunilla Källenius Karolinska Institute
Francis Drobniewski
Francis Drobniewski Imperial College London
Stefan B. Svenson
Stefan B. Svenson Swedish University of Agricultural Sciences
Daniela M. Cirillo
Daniela M. Cirillo Vita-Salute San Raffaele University
Stefan Niemann
Stefan Niemann Research Center Borstel - Leibniz-Center for Medicine and Biosciences
Sabine Rüsch-Gerdes
Sabine Rüsch-Gerdes Kiel University
Moses Joloba
Moses Joloba Makerere University
Sebastien Gagneux
Sebastien Gagneux University of Basel
Leen Rigouts
Leen Rigouts Institute of Tropical Medicine Antwerp
Christian G. Giske
Christian G. Giske Karolinska University Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students studying Microbiology in the USA, exploring related online degrees can open diverse career opportunities. Fields like health information management and medical coding are closely linked to microbiological research and healthcare services.

One promising career path includes becoming a certified professional coder. Programs such as cpc certification equip you with skills in medical coding, which is vital for accurate healthcare documentation and billing processes.

Another avenue is Health Information Management, where professionals ensure healthcare data accuracy and security. The role comes with attractive salaries and growth prospects, outlined in this health information management job description and salary overview.

To enter this growing field, consider enrolling in an accredited online health information management degree cahiim. These programs offer flexibility and meet industry standards, ensuring you gain recognized credentials.

Additionally, if you seek a quicker path, look into the best fastest online medical billing and coding certificate programs. These certificates provide essential skills in a condensed timeframe, enabling rapid entry into healthcare administration roles.

Best Scientists Citing Sven Hoffner

Trending Scientists

Recently Published Articles